Analyst Ratings for TherapeuticsMD (TXMD)

TXMD Rating Summary

TXMD Price Target Summary

* Over Last 12-Mos
  |   Expand Research on TXMD
Overall Rating: BUY   Rating Trend: Up   Avg. $ Target: $22.07 (+1924.5%) * Over Last 12-Mos
Rating Score: 8 / 10   Percentile Rank: 83%
Date Firm Analyst Type Rating
(Past)
PT
(Past)
Start $
(End $)
% Chg. Details
8/7/2020 Jefferies Chris Howerton Downgrade Underperform
(Hold)
1.20
(1.25)
2.05
(1.09)
-46.83% Details
5/19/2020 JPMorgan Chris Schott Downgrade Neutral
(Overweight)
N/A
(N/A)
1.17
(1.09)
-6.84% Details